Regional difference in induction of heme oxygenase-1 protein following rat transient forebrain ischemia

A Takeda, T Kimpara, H Onodera, Y Itoyama… - Neuroscience …, 1996 - Elsevier
A Takeda, T Kimpara, H Onodera, Y Itoyama, S Shibahara, K Kogure
Neuroscience letters, 1996Elsevier
Heme oxygenase (HO) is a rate-limiting enzyme in heme catabolism, the end products of
which include iron, carbon monoxide and bilirubin. We investigated the changes in
expression of an inducible form, heme oxygenase-1 (HO-1), and a constitutive form, HO-2, in
rat brain following 20 min of forebrain ischemia, using specific antisera for HO-1 and HO-2.
HO-1 protein was remarkably induced in brain following ischemia, while the level of HO-2
protein was not noticeably affected. The level of HO-1 protein expression was maximal at 12 …
Heme oxygenase (HO) is a rate-limiting enzyme in heme catabolism, the end products of which include iron, carbon monoxide and bilirubin. We investigated the changes in expression of an inducible form, heme oxygenase-1 (HO-1), and a constitutive form, HO-2, in rat brain following 20 min of forebrain ischemia, using specific antisera for HO-1 and HO-2. HO-1 protein was remarkably induced in brain following ischemia, while the level of HO-2 protein was not noticeably affected. The level of HO-1 protein expression was maximal at 12 h, which is in good agreement with the time course of the HO-1 mRNA induction. In the cortical mantle, most of the cells expressing increased HO-1 protein were identified as pyramidal neurons and astrocytes by their shapes and locations. In hippocampal CA-2 and CA-3 subfields, prominent induction was observed in astrocytes rather than in neuronal cells. By contrast, the HO-1 protein was not detected in the CAI subfield following the insult, although the increased level of transcripts was evident in neurons and glial cells. These results suggest that not only in neuronal cells but also in astrocytes within the CAI subfield, there may be an impairment of protein metabolism, preceding the delayed CA1 pyramidal cell losses.
Elsevier